跳至主要内容
临床试验/NCT00855829
NCT00855829已完成1 期

A Single-Center, Randomized, Controlled, Double-Blind Feasibility Study Designed to Assess the Safety Performance of ActiLady Prototype in Adult Female Subjects With Dysmenorrhea.

Hadassah Medical Organization4 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2010年5月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
24
试验地点
4
主要终点
To evaluate the safety of a novel method and device called ActiLady.

研究概览

简要总结

ActiLady refers is employing targeted pressure waves, with the goal of reducing the pain associated with menstruation (clinically known as dysmenorrhea).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged 18-35 years
  • Regular menstrual cycles (26-35 days); average duration of menstruation ≥5 days for the 4 months preceding the beginning of the trial.
  • Dysmenorrhea pain score >50mm on a 100mm visual analog scale (VAS) for the maximum abdominal pain
  • Analgesic use during every menstrual cycle
  • Non-pregnant, with no intentions to get pregnant during the clinical trial
  • Agrees not to use oral contraceptives or an intrauterine device (IUD) during the trial period
  • Agrees not to use analgesics, except during permitted period (16:00-04:00 the next day, daily)
  • Consents to the use of pads or other vaginal devices throughout the trial period
  • Subject is able to comply with all the requirements of the study and agrees to participate in all the activities of the study
  • Signed written informed consent form (ICF) to participate in the study

排除标准

  • Pregnant or lactating women
  • Used hormonal and/or oral contraceptives in the preceding 4 months
  • Use of an IUD in the preceding 4 months
  • Previous diagnosis of secondary dysmenorrhea
  • Urinary incontinence
  • Duration of menstruation is <5 days
  • Subjects with a known sensitivity to mechanical vibrations and/or silicone
  • Participation in current or recent clinical trial within 30 days prior to baseline visit

结局指标

主要结局

To evaluate the safety of a novel method and device called ActiLady.

时间窗: 6 months

次要结局

  • * Evaluate the pain-reducing effect of ActiLady on dysmenorrhea. * Study the relationship between menses flux and dysmenorrhea. [Time Frame: 6 months] [Designated as safety issue: No ] * Optimize treatment procedure and wave form.(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ezra Yosi

Prof. Yossi Ezra

Hadassah Medical Organization

研究点 (4)

Loading locations...

相似试验

A Feasibility Study Designed to Assess the Efficacy... | 临床试验